Centaurus Financial, Inc. Abb Vie Inc. Transaction History

Centaurus Financial, Inc.

$1.44 Billion
Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Centaurus Financial, Inc. holds 8,319 shares of ABBV stock, worth $1.37 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,319

Previous 7,120 16.84%

Holding current value

$1.37 Million

Previous $1.22 Million 34.48%

% of portfolio

0.11%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $196,444 - $238,996	1,199 Added 16.84%	8,319 $1.64 Million
Q2 2024 Sep 20, 2024	SELL	$154.79 - $180.76 $33,279 - $38,863	-215 Reduced 2.93%	7,120 $1.22 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $48,105 - $54,812	-301 Reduced 3.94%	7,335 $1.34 Million
Q4 2023 Feb 26, 2024	SELL	$137.6 - $154.97 $118,748 - $133,739	-863 Reduced 10.15%	7,636 $1.18 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $53,302 - $61,705	399 Added 4.93%	8,499 $1.27 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $848,594 - $1.06 Million	-6,404 Reduced 44.15%	8,100 $1.09 Million
Q1 2023 May 17, 2023	BUY	$144.61 - $166.54 $136,078 - $156,714	941 Added 6.94%	14,504 $2.31 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $121,159 - $145,302	-876 Reduced 6.07%	13,563 $2.19 Million
Q3 2022 Dec 05, 2022	BUY	$134.21 - $153.93 $89,518 - $102,671	667 Added 4.84%	14,439 $1.94 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $530,112 - $673,945	-3,852 Reduced 21.86%	13,772 $2.11 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $8,974 - $11,135	-68 Reduced 0.38%	17,624 $2.86 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $233,552 - $295,511	2,174 Added 14.01%	17,692 $2.4 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $12,555 - $14,252	118 Added 0.77%	15,518 $1.67 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $324,257 - $361,241	3,082 Added 25.02%	15,400 $1.74 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $385,568 - $424,464	3,769 Added 44.09%	12,318 $1.33 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $57,147 - $77,155	-710 Reduced 7.67%	8,549 $916,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $100,514 - $117,971	-1,170 Reduced 11.22%	9,259 $811,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $161,487 - $216,094	2,201 Added 26.75%	10,429 $1.02 Million
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $261,741 - $396,831	4,058 Added 97.31%	8,228 $627,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $300,782 - $376,342	4,170 New	4,170 $369,000
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $77 - $96	-1 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $1.22 Million - $1.36 Million	-13,745 Reduced 99.99%	1 $105,000
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $1.09 Million - $1.29 Million	12,130 Added 750.62%	13,746 $1.27 Million
Q1 2018 May 07, 2018	BUY	$92.01 - $123.21 $148,688 - $199,107	1,616 New	1,616 $153,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Abb Vie Inc. Transaction History